241.58
Schlusskurs vom Vortag:
$242.91
Offen:
$243.63
24-Stunden-Volumen:
961.07K
Relative Volume:
0.72
Marktkapitalisierung:
$33.69B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-105.77
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
+4.47%
1M Leistung:
+2.63%
6M Leistung:
+75.29%
1J Leistung:
+40.60%
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NTRA
Natera Inc
|
241.58 | 33.87B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
625.98 | 240.25B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.01 | 169.58B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
693.85 | 55.18B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
235.31 | 40.71B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.05 | 39.30B | 6.95B | 1.30B | 1.15B | 4.5696 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
iA Global Asset Management Inc. Acquires Shares of 6,659 Natera, Inc. $NTRA - MarketBeat
GDS Wealth Management Has $11.61 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Is It Too Late To Consider Natera (NTRA) After A 4x Three Year Share Price Surge - Yahoo Finance
How Natera Inc. (NTRA) Affects Rotational Strategy Timing - Stock Traders Daily
How Investors May Respond To Natera (NTRA) MRD Breakthrough, AI Push And 2025 Revenue Outlook - simplywall.st
Fesko John, president at Natera, sells $4.2 million in NTRA stock By Investing.com - Investing.com India
Fesko John, president at Natera, sells $4.2 million in NTRA stock - Investing.com India
Lack of Natera (NTRA) Exposure Weighs on Mid-Cap Fund Performance - Insider Monkey
Lack of Natera (NTRA) Exposure Weighs on Voya MidCap Opportunities Fund Performance - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Buys 19,166 Shares of Natera, Inc. $NTRA - MarketBeat
Allstate Corp Makes New $775,000 Investment in Natera, Inc. $NTRA - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 339 Shares - MarketBeat
Solomon Moshkevich Sells 293 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CEO Chapman sells $17.2 million in shares - Investing.com
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 1,590 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 71,932 Shares - MarketBeat
Solomon Moshkevich Sells 23,205 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 17,806 Shares - MarketBeat
Natera CFO Brophy sells $14.6 million in NTRA stock By Investing.com - Investing.com UK
Natera CFO Brophy sells $14.6 million in NTRA stock - Investing.com
Natera CEO Chapman sells $17.2 million in shares By Investing.com - Investing.com UK
Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock By Investing.com - Investing.com Nigeria
Natera president sells $5.5 million in NTRA stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock - Investing.com UK
Natera’s sec. Daniel Rabinowitz sells $4.6m in NTRA stock - Investing.com
Natera president sells $5.5 million in NTRA stock - Investing.com
Natera Executives and Director Engage in Significant Stock Transactions - TradingView
Natera Expands MRD Ambitions With Latitude Study And AI NVIDIA Deal - simplywall.st
Aubrey Capital Management Ltd Takes $2.61 Million Position in Natera, Inc. $NTRA - MarketBeat
Rakuten Investment Management Inc. Acquires New Position in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Unveils Promising Study Results for Colorectal Can - GuruFocus
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer - Yahoo Finance
Natera to present EXPAND trial data on fetal genetic screening By Investing.com - Investing.com India
Natera (NTRA) Surged as Results Beat Expectations - Insider Monkey
Natera to present EXPAND trial data on fetal genetic screening - Investing.com
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting - Yahoo Finance
Campbell & CO Investment Adviser LLC Acquires Shares of 5,145 Natera, Inc. $NTRA - MarketBeat
Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin - MSN
Massachusetts Financial Services Co. MA Sells 17,498 Shares of Natera, Inc. $NTRA - MarketBeat
Assessing Natera (NTRA) Valuation After AI Oncology Advances And Strong 2025 Growth Guidance - simplywall.st
Short Interest in Natera, Inc. (NASDAQ:NTRA) Rises By 39.8% - MarketBeat
Natera prenatal test false advertising $8.25M class action settlement explained: Are you owed money? - Claim Depot
AI-Enhanced Signatera Upgrade And NVIDIA Deal Could Be A Game Changer For Natera (NTRA) - simplywall.st
Is It Too Late To Consider Natera (NTRA) After Its Strong 1-Year Share Price Run? - simplywall.st
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Sumitomo Mitsui Trust Group Inc. Sells 88,968 Shares of Natera, Inc. $NTRA - MarketBeat
Assessing Whether Natera (NTRA) Is Overvalued After Strong Longer Term Share Price Gains - Yahoo Finance
Natera unveils AI model to enhance cancer recurrence risk assessment By Investing.com - Investing.com Nigeria
How Investors Are Reacting To Natera (NTRA) NVIDIA-Backed Multimodal AI And Precision Diagnostics Advances - Yahoo Finance
NTRA & NVDA Partner to Improve AI Models for Precision Medicine - sharewise.com
Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing - TipRanks
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):